Jpmorgan Chase & CO Galera Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.17 - $3.0 $112 - $1,980	-660 Reduced 96.49%	24 $0
Q2 2023 Aug 11, 2023	BUY	$2.5 - $3.42 $1,650 - $2,257	660 Added 2750.0%	684 $2,000
Q4 2021 Feb 10, 2022	SELL	$1.27 - $8.28 $34 - $223	-27 Reduced 52.94%	24 $0
Q3 2021 Nov 12, 2021	BUY	$7.04 - $10.49 $359 - $534	51 New	51 $0

909K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $1.07M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.